1330076-52-2

Salmeterol USP RC H SalMeterol IMpurity H Salmeterol Impurity 14 salmeterol impurities1071 SalMeterol Related CoMpound H Salmeterol USP Related Compound H SalMeterol Xinafoate Adduct IMpurity Salmeterol Impurity H (Xinafoate Adduct Impurity) SalMeterol Xinafoate Adduct IMpurity DISCONTINUED Salmeterol Impurity 14 (Xinafoate Adduct Impurity) Salmeterol Impurity 9（Salmeterol Related Compound H） Salmeterol Related Compound H (Salmeterol Xinafoate Adduct Impurity) 1-Hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid 1-Hydroxy-4-(2-hydroxy-5-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylaMino]ethyl}benzyl)naphthalene-2-carboxylic Acid Salmeterol Related Compound H (1-hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amin (1609680) 1-hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenyl]methyl]naphthalene-2-carboxylic acid 1-Hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]phenyl]methyl]-2-naphthalenecarboxylic acid 2-Naphthalenecarboxylic acid, 1-hydroxy-4-[[2-hydroxy-5-[1-hydroxy-2-[[6-(4-phenylbutoxy)hexyl]amino]ethyl]phenyl]methyl]- Salmeterol Related Compound H (15 mg) (1-hydroxy-4-[2-hydroxy-5-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)benzyl]-2-naphthoic acid)